Novo Nordisk targets filing this year for insulin, GLP-1 combo IcoSema – FirstWord Pharma

Weightloss News
Novo Nordisk targets filing this year for insulin, GLP-1 combo IcoSema. Top Story … IcoSema also showed better weight loss effects, with patients …